Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salmon, D. A.
Right arrow Articles by Halsey, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salmon, D. A.
Right arrow Articles by Halsey, N. A.
Related Collections
Right arrow Health Policy
Right arrow Immunization/Vaccines
Right arrow Government
June 2004, Vol 94, No. 6 | American Journal of Public Health 947-950
© 2004 American Public Health Association

VACCINES, UNCERTAINTIES, AND ETHICAL CHALLENGES

Enhancing Public Confidence in Vaccines Through Independent Oversight of Postlicensure Vaccine Safety

Daniel A. Salmon, PhD, MPH, Lawrence H. Moulton, PhD and Neal A. Halsey, MD

The authors are with the Institute for Vaccine Safety, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Md.

Correspondence: Requests for reprints should be sent to Daniel A. Salmon, 615 N Wolfe St, Suite 5034, Baltimore, MD 21205 (e-mail: dsalmon{at}jhsph.edu).

ABSTRACT

The National Immunization Program of the Centers for Disease Control and Prevention is responsible for controlling infectious diseases through vaccination, but the program also plays a key role in postlicensure vaccine safety assessment. The time has come to separate postlicensure vaccine safety assessment from vaccine risk management as recommended by the National Research Council of the National Academy of Sciences.

The National Transportation Safety Board offers a useful model for developing an independent National Vaccine Safety Board that would have the authority to leverage resources and expertise of various government agencies, academia, and industry to oversee postlicensure vaccine safety investigations. Such a board would have been useful in recent vaccine safety concerns, and its independence from government programs would ensure optimal vaccine safety and enhance public confidence in vaccines.




This article has been cited by other articles:


Home page
 Health Aff (Millwood)Home page
J. Colgrove and R. Bayer
Could It Happen Here? Vaccine Risk Controversies And The Specter Of Derailment
Health Aff., May 1, 2005; 24(3): 729 - 739.
[Abstract] [Full Text] [PDF]

Home page
 AJPHHome page
R. Bernier and K. Midthun
Getting the Science Right and Doing the Right Science in Vaccine Safety
Am J Public Health, June 1, 2004; 94(6): 914 - 917.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Public Health Association